Product Information

PREGABALIN ER 165 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $1.7926 per EA under NDC 72205007830. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Apr 13, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PREGABALIN ER 165 MG TABLET

PREGABALIN
$1.7926per EA
High Outlier
DEA Schedule CV

Strength

165 mg/1

NDC

72205007830

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA213226

FDA Approved

4/13/2021

TE Code

AB

On Market Since

4/13/2021

Price Statistics

The NADAC for PREGABALIN ER 165 MG TABLET has been published 136 times since Apr 17, 2024, and over the history we have for it it has declined 46.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7926 per EA
All-time high$3.6487 (Jun 11, 2025)
All-time low$1.6301 (Oct 21, 2026)
52-week high$2.2439
52-week low$1.6301
Median price$2.2439
Average price$2.4871
Largest weekly change-30.2% (Aug 21, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+10.0%

1M

-1.2%

3M

-8.0%

6M

-17.3%

1Y

-20.1%

3Y

N/A

5Y

N/A

All

-46.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PREGABALIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN ER 165 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN ER 165 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $1.7926 per EA (NDC 72205007830), effective Nov 18, 2026.

How has the price of PREGABALIN ER 165 MG TABLET changed over time?

Over the history we have for it, the NADAC for PREGABALIN ER 165 MG TABLET has declined 46.1%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for PREGABALIN ER 165 MG TABLET?

Since Apr 17, 2024, the NADAC for PREGABALIN ER 165 MG TABLET has ranged from a low of $1.6301 (Oct 21, 2026) to a high of $3.6487 (Jun 11, 2025), with a median of $2.2439 per EA.

Are there cheaper alternatives to PREGABALIN ER 165 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PREGABALIN ER 165 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PREGABALIN ER 165 MG TABLET?

PREGABALIN ER 165 MG TABLET (NDC 72205007830) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.